Related Experiment Video
Updated: Jun 10, 2026
03:57
Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy
Published on: July 14, 2023
[Tissue engineering of parathyroid gland].
F Iovino1, G Armano, P P Auriemma
1Dipartmento di Scienze Anestesiologiche, Seconda Universitá degli Studi di Napoli, Italy.
Il Giornale Di Chirurgia
|July 22, 2010
Summary
Engineered collagen scaffolds support human parathyroid cells, offering a promising approach for treating hypoparathyroidism. This bioengineered device aims to restore parathyroid hormone (PTH) secretion in patients post-thyroidectomy.
Area of Science:
- Tissue Engineering
- Regenerative Medicine
- Endocrinology
Background:
- Postoperative hypoparathyroidism is a common complication after thyroid or parathyroid surgery.
- Current parathyroid tissue transplantation methods yield disappointing results.
- Bioengineered devices for PTH secretion are needed for iatrogenic hypoparathyroidism.
Purpose of the Study:
- To optimize human parathyroid cell cultures for enhanced PTH secretion.
- To engineer functional human parathyroid glands using 3D collagen scaffolds.
Main Methods:
- Parathyroid cells from uremic patients were cultured on collagen scaffolds in low-calcium media.
- Cell cultures were observed using light and ESEM microscopy and MTT assays for 10 weeks.
- Parathyroid hormone (PTH) concentration in culture media was measured over several weeks.
Main Results:
- Human parathyroid cells adhered and organized on collagen scaffolds, maintaining epithelial-like morphology for 10 weeks.
- Cells exhibited good proliferation rates and discrete PTH production.
- The cellular population was predominantly parathyroid cells (90-95%).
Conclusions:
- Using parathyroid cells from secondary hyperparathyroidism patients is effective for scaffold engineering.
- Bioengineered scaffolds can prevent cell dispersion and allow easy removal if complications arise.
- These findings support further development for in vivo animal models.
